| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
27,157 |
22,335 |
$1.14M |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
2,410 |
1,952 |
$142K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,446 |
1,869 |
$124K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,688 |
4,479 |
$104K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
952 |
810 |
$88K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,912 |
1,691 |
$67K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,372 |
1,150 |
$51K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,480 |
1,361 |
$48K |
| 99406 |
|
5,786 |
4,812 |
$40K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,033 |
1,645 |
$32K |
| 80305 |
|
1,123 |
965 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
426 |
375 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
883 |
716 |
$8K |
| 87631 |
|
100 |
91 |
$7K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
883 |
697 |
$6K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
187 |
173 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
2,627 |
2,287 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,753 |
1,441 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
188 |
173 |
$4K |
| 87428 |
|
564 |
528 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
80 |
79 |
$3K |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
1,260 |
1,056 |
$2K |
| 99443 |
|
56 |
54 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
68 |
68 |
$1K |
| 99442 |
|
51 |
47 |
$1K |
| 81002 |
|
379 |
322 |
$813.98 |
| 71046 |
Radiologic examination, chest; 2 views |
63 |
55 |
$739.65 |
| 99497 |
|
162 |
144 |
$392.92 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
641 |
502 |
$289.23 |
| 90686 |
|
17 |
16 |
$258.24 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
22 |
18 |
$69.32 |
| 90674 |
|
15 |
13 |
$22.94 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
42 |
32 |
$15.78 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
48 |
24 |
$1.88 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
59 |
52 |
$0.00 |
| 90670 |
|
44 |
44 |
$0.00 |
| 90756 |
|
16 |
15 |
$0.00 |
| 90648 |
|
51 |
51 |
$0.00 |
| 90700 |
|
18 |
17 |
$0.00 |
| 36416 |
|
27 |
25 |
$0.00 |
| 90680 |
|
16 |
16 |
$0.00 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
59 |
52 |
$0.00 |
| 90723 |
|
20 |
20 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
15 |
13 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
15 |
13 |
$0.00 |
| 0001A |
|
13 |
13 |
$0.00 |